Copyright
©The Author(s) 2022.
World J Clin Cases. Sep 26, 2022; 10(27): 9911-9920
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9911
Published online Sep 26, 2022. doi: 10.12998/wjcc.v10.i27.9911
Parameter (units) | Measured value | Normal value |
White blood cell (109/L) | 12.9 | 3.6-8.9 |
Neu (%) | 83.4 | 37-72 |
Lym (%) | 13.4 | 25-48 |
Mon (%) | 2.6 | 2-12 |
Eos (%) | 0.4 | 1-9 |
Bas (%) | 0.2 | 0-2 |
Red blood cell (1012/L) | 3.13 | 3.8-5.04 |
Platelet (109/L) | 221 | 153-346 |
Aspartate transaminase (IU/L) | 14 | 5-37 |
Alanine aminotransferase (IU/L) | 12 | 6-43 |
Lactic acid dehydrogenase (IU/L) | 164 | 119-221 |
Alkaline phosphatase (IU/L) | 159 | 110-348 |
Gamma-glutamyl transpeptidase (IU/L) | 15 | 0-75 |
Total bilirubin (mg/dL) | 0.5 | 0.4-1.2 |
Total protein (g/dL) | 7.4 | 6.5-8.5 |
Albumin (g/dL) | 4.5 | 3.8-5.2 |
Creatine kinase (U/L) | 95 | 47-200 |
Blood urea nitrogen (mg/dL) | 13 | 9-21 |
Creatinine (mg/dL) | 0.76 | 0.5-0.8 |
Amylase (IU/L) | 98 | 43-124 |
Sodium (mEq/L) | 140 | 135-145 |
Potassium (mEq/L) | 3.3 | 3.5-5 |
Chloride (mEq/L) | 110 | 96-107 |
C-reactive protein (mg/dL) | 0.03 | 0-0.29 |
Plasma glucose (mg/dL) | 156 | 65-109 |
Activated partial thromboplastin time (Seconds) | 24.8 | 23-36 |
Prothrombin time-international normalized ratio | 1.1 | 0.85-1.15 |
D-dimer (μg/mL) | 1.1 | 0-1 |
Case No. | Year | Age | Sex | Underlying disease | Antiplatelet therapy | Anticoagulation therapy | Symptoms | Imaging findings | Complications | Prognosis | Prognosis time | Ref. |
1 | 1998 | 64 | M | Ischemic heart disease | None | None | Retrostemal pain and coffee-ground vomitus | CT: A non-enhancing low-density submucosal columnar lesion in the mid- and lower oesophagus consistent with a submucosal haematoma. MRI: Intermediate signal intensity on T1-weighted images and hyperintense signal on T2-weighted images of this lesion. | None | Recovered | N/A | Yuen et al[9] |
2 | 2000 | 67 | M | Unruptured cerebral aneurysm | None | Heparin | Hematemesis | CT: A longitudinal water density mass without enhancement in the distal half of the esophageal lumen. It extended from about 3 cm below the level of the tracheal carina to the esophagocardiac junction. | None | Recovered | N/A | Yamashita et al[10] |
3 | 2001 | 84 | F | Dissecting aortic aneurysm | None | None | Chest discomfort and hematemesis | CT: Partial thickness of the esophageal wall which was not enhanced by contrast medium. | None | Recovered | N/A | Kise et al[11] |
4 | 2010 | 68 | F | Cerebrovascular disease | A | None | Hematemesis and retrostemal pain | None | None | Recovered | N/A | Zimmer et al[12] |
5 | 2013 | 32 | F | Neurofibromatosis type 1 | None | None | Sever central chest pain and interscapular pain associated with dysphagia | N/A | Massive bleeding with hypovolemic shock due to dissecting intramural hematoma of the esophagus | Dead | 6 hours | Pomara et al[13] |
6 | 2014 | 74 | M | Cerebral infarction and chronic hepatitis C | A | None | Hematemesis | None | None | Recovered | N/A | Oe et al[2] |
7 | 2016 | 70 | F | Unruptured cerebral aneurysm | A | Heparin | Epigastric pain and nausea | Unknown | Unknown | Recovered | N/A | Fujimoto et al[7] |
8 | 2017 | 81 | M | Idiopathic thrombocytopenic purpura | None | None | Chest pain and dysphagia | CT: A 17-cm long segment of homogeneous, soft tissue like density in the mid-to-distal esophagus with smooth eccentric configuration causing luminal narrowing. The maximal esophageal wall measures approximately 26 mm in thickness. Upper gastrointestinal contrast study: A large eccentric luminal narrowing caused by a mural wall compression of the mid-to-distal esophagus, confirming the submucosal hematoma. | None | Recovered | N/A | Sharma et al[14] |
9 | 2017 | 85 | F | Atrial fibrillation | None | Dabigatran | Hemoptysis | Unknown | Unknown | Recovered | N/A | Trip et al[15] |
10 | 2017 | 75 | F | Unruptured cerebral aneurysm | A+C | Heparin + Argatroban | Hematemesis | CT: Dilatation of the entire esophagus and the soft tissue shadow filled on the dorsal side that was ventrally displacing the lumen. | None | Recovered | N/A | Ito et al[16] |
11 | 2019 | 65 | F | Unruptured cerebral aneurysm | A | Heparin | Hematemesis | Unknown | Unknown | Recovered | N/A | Fujii et al[5] |
12 | 2019 | 73 | F | Unruptured cerebral aneurysm | A+C | Heparin | Epigastric pain and hematemesis | Unknown | Unknown | Recovered | N/A | Fujii et al[5] |
13 | 2019 | 65 | F | Unruptured cerebral aneurysm | A+C | Heparin | Epigastric pain | Unknown | Unknown | Recovered | N/A | Fujii et al[5] |
14 | 2020 | 73 | F | Unruptured cerebral aneurysm | A+C | Heparin | Hematemesis | CT: A dilatation from the middle to lower esophagus, and that the esophageal lumen was almost entirely filled with hematomas. An occupying lesion with a relatively clear boundary was observed under the mucosa at the esophagogastric junction, which had partial contrast effects. | None | Recovered | N/A | N/A |
- Citation: Oba J, Usuda D, Tsuge S, Sakurai R, Kawai K, Matsubara S, Tanaka R, Suzuki M, Takano H, Shimozawa S, Hotchi Y, Usami K, Tokunaga S, Osugi I, Katou R, Ito S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Nomura T, Sugita M. Hemorrhagic shock due to submucosal esophageal hematoma along with mallory-weiss syndrome: A case report. World J Clin Cases 2022; 10(27): 9911-9920
- URL: https://www.wjgnet.com/2307-8960/full/v10/i27/9911.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i27.9911